![Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy ... Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy ...](https://www.europeanurology.com/cms/asset/3cc5e577-f57e-40ea-8ea2-f38224225f29/gr1.jpg)
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy ...
![Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance | Prostate Cancer and Prostatic Diseases Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-018-0074-5/MediaObjects/41391_2018_74_Fig1_HTML.png)
Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance | Prostate Cancer and Prostatic Diseases
![When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2015/02/tnpcil2.png)
When should therapeutic intervention take place for men on active surveillance? | THE "NEW" PROSTATE CANCER INFOLINK
![Figure 1 from Watchful waiting vs. active surveillance: Which treatment option is right for patients with localized prostate cancer? | Semantic Scholar Figure 1 from Watchful waiting vs. active surveillance: Which treatment option is right for patients with localized prostate cancer? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3dc3d6d5d2304855f3aa94c924f421b9313d69e6/2-Figure1-1.png)
Figure 1 from Watchful waiting vs. active surveillance: Which treatment option is right for patients with localized prostate cancer? | Semantic Scholar
![Watchful waiting vs. active surveillance: Which treatment option is right for patients with localized prostate cancer? - MedCrave online Watchful waiting vs. active surveillance: Which treatment option is right for patients with localized prostate cancer? - MedCrave online](https://medcraveonline.com/UNOAJ/images/UNOAJ-06-00228-g001.png)
Watchful waiting vs. active surveillance: Which treatment option is right for patients with localized prostate cancer? - MedCrave online
![Gleason 3+4 Active Surveillance, PSMA Alternatives, and More | Answering YouTube Comments #46 | PCRI - YouTube Gleason 3+4 Active Surveillance, PSMA Alternatives, and More | Answering YouTube Comments #46 | PCRI - YouTube](https://i.ytimg.com/vi/h0OZxFMw1eE/sddefault.jpg)
Gleason 3+4 Active Surveillance, PSMA Alternatives, and More | Answering YouTube Comments #46 | PCRI - YouTube
![Pathological outcome for Chinese patients with low-risk prostate cancer eligible for active surveillance and undergoing radical prostatectomy: comparison of six different active surveillance protocols | HKMJ Pathological outcome for Chinese patients with low-risk prostate cancer eligible for active surveillance and undergoing radical prostatectomy: comparison of six different active surveillance protocols | HKMJ](https://www.hkmj.org/system/files/hkmj166194-table-5.jpg)
Pathological outcome for Chinese patients with low-risk prostate cancer eligible for active surveillance and undergoing radical prostatectomy: comparison of six different active surveillance protocols | HKMJ
Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review
![Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure | Nature Reviews Urology Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure | Nature Reviews Urology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrurol.2017.26/MediaObjects/41585_2017_Article_BFnrurol201726_Fig3_HTML.jpg)
Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure | Nature Reviews Urology
![Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer - European Urology Oncology Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer - European Urology Oncology](https://euoncology.europeanurology.com/cms/asset/e38e62f6-4b0c-4321-92b4-bb99b2c0f9cc/gr1.jpg)
Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer - European Urology Oncology
![Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes - ScienceDirect Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1558767320301166-gr1.jpg)
Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes - ScienceDirect
![An active surveillance program in oral preneoplasia and translational oncology benefit - Archibald - 2021 - Laryngoscope Investigative Otolaryngology - Wiley Online Library An active surveillance program in oral preneoplasia and translational oncology benefit - Archibald - 2021 - Laryngoscope Investigative Otolaryngology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/01ea82a5-cf2d-453e-bcc1-ceb253f0c583/lio2612-fig-0001-m.jpg)
An active surveillance program in oral preneoplasia and translational oncology benefit - Archibald - 2021 - Laryngoscope Investigative Otolaryngology - Wiley Online Library
![PI-RADS, Active Surveillance Protocols for 3+3=6 & 3+4=7, & Genomic/Genetics Tests | Mark Scholz, MD - YouTube PI-RADS, Active Surveillance Protocols for 3+3=6 & 3+4=7, & Genomic/Genetics Tests | Mark Scholz, MD - YouTube](https://i.ytimg.com/vi/mnHGyEsxXO4/maxresdefault.jpg)